BLUE - bluebird bio, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
Cambridge,
United States
Type: Equity
BLUE price evolution
BLUE
| (in millions $) | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 | 31 Jan 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $165.35 | $172.87 | $239.04 | $113.01 |
| Short term investments | $8.95 | $72.43 | $79.21 | $67.32 |
| Net receivables | $23 | $15.44 | $15.54 | $10.79 |
| Inventory | $20.97 | $13.64 | $3.81 | |
| Total current assets | $247.08 | $287.98 | $351.07 | $199.49 |
| Long term investments | $1.41 | |||
| Property, plant & equipment | $304.69 | $313.08 | $278.87 | $291.36 |
| Goodwill & intangible assets | $11.01 | $11.14 | $11.26 | $10.51 |
| Total noncurrent assets | $366.53 | $375.42 | $341.67 | $355.41 |
| Total investments | $8.95 | $72.43 | $79.21 | $68.73 |
| Total assets | $613.61 | $663.39 | $692.74 | $554.9 |
| Current liabilities | ||||
| Accounts payable | $19.85 | $10.89 | $19.23 | $25.09 |
| Deferred revenue | $9.65 | |||
| Short long term debt | $71.68 | $67.59 | $51.4 | $51.16 |
| Total current liabilities | $158.96 | $135.02 | $115.93 | $128.24 |
| Long term debt | $232.02 | $239.27 | $221.97 | $230.23 |
| Total noncurrent liabilities | $232.12 | $239.36 | $222.06 | $230.32 |
| Total debt | $303.71 | $306.86 | $273.38 | $281.39 |
| Total liabilities | $391.07 | $374.37 | $338 | $358.56 |
| Shareholders' equity | ||||
| Retained earnings | -$4109.9 | -$4038.17 | -$3965.26 | -$3986.5 |
| Other shareholder equity | -$2.23 | -$2.36 | -$3.09 | -$4.07 |
| Total shareholder equity | $222.54 | $289.02 | $354.74 | $196.34 |
| (in millions $) | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $113.01 | $161.16 | $317.7 | $327.21 |
| Short term investments | $67.32 | $138.34 | $833.55 | $779.25 |
| Net receivables | $10.79 | $11.39 | $26.81 | $12.83 |
| Inventory | ||||
| Total current assets | $199.49 | $336.52 | $1215.54 | $1152.17 |
| Long term investments | $1.41 | $97.11 | $122.89 | $131.51 |
| Property, plant & equipment | $291.36 | $101.24 | $346.85 | $337.06 |
| Goodwill & intangible assets | $10.51 | $5.65 | $23.17 | $27.45 |
| Total noncurrent assets | $355.41 | $257.27 | $565.72 | $575.25 |
| Total investments | $68.73 | $235.46 | $956.44 | $910.75 |
| Total assets | $554.9 | $593.79 | $1781.25 | $1727.42 |
| Current liabilities | ||||
| Accounts payable | $25.09 | $25.88 | $21.6 | $42.99 |
| Deferred revenue | $28.08 | $18.27 | ||
| Short long term debt | $51.16 | $23.15 | $25.02 | $20.18 |
| Total current liabilities | $128.24 | $152.99 | $203.59 | $223.58 |
| Long term debt | $230.23 | $66.43 | $168 | $170.81 |
| Total noncurrent liabilities | $230.32 | $66.53 | $222.61 | $218.85 |
| Total debt | $281.39 | $89.58 | $193.02 | $190.99 |
| Total liabilities | $358.56 | $219.52 | $426.2 | $442.43 |
| Shareholders' equity | ||||
| Retained earnings | -$3986.5 | -$3719.93 | -$2900.55 | -$2281.85 |
| Other shareholder equity | -$4.07 | -$2.91 | -$5.5 | -$1.89 |
| Total shareholder equity | $196.34 | $374.28 | $1355.06 | $1284.99 |
| (in millions $) | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 | 31 Dec 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $12.39 | $6.89 | $2.38 | $0.06 |
| Cost of revenue | $10.96 | $9.56 | $3.38 | $0.02 |
| Gross Profit | $1.44 | -$2.67 | -$0.99 | $0.04 |
| Operating activities | ||||
| Research & development | $45.46 | $42.27 | $46.14 | $45.9 |
| Selling, general & administrative | $40.7 | $40.35 | $37.35 | $30.71 |
| Total operating expenses | $86.17 | $82.62 | -$9.43 | -$25.39 |
| Operating income | -$84.73 | -$85.3 | $8.44 | $25.43 |
| Income from continuing operations | ||||
| EBIT | -$74.19 | -$75.67 | $18.41 | $31.97 |
| Income tax expense | -$0.08 | $0.11 | ||
| Interest expense | -$2.45 | -$2.68 | -$2.83 | -$0.37 |
| Net income | ||||
| Net income | -$71.73 | -$72.91 | $21.24 | $32.23 |
| Income (for common shares) | -$71.73 | -$72.91 | $21.24 | $32.23 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3.6 | $3.66 | $250.73 | $44.67 |
| Cost of revenue | $10.08 | $38.86 | $5.4 | $2.98 |
| Gross Profit | -$6.48 | -$35.2 | $245.34 | $41.7 |
| Operating activities | ||||
| Research & development | $240.76 | $319.95 | $587.96 | $582.41 |
| Selling, general & administrative | $136.91 | $209.97 | $286.9 | $271.36 |
| Total operating expenses | $280.61 | $555.72 | $874.85 | $853.77 |
| Operating income | -$287.09 | -$590.91 | -$629.51 | -$812.08 |
| Income from continuing operations | ||||
| EBIT | -$267.49 | -$820 | -$629.55 | -$824.91 |
| Income tax expense | $0.12 | $0.26 | $0.69 | -$0.55 |
| Interest expense | -$1.03 | -$0.88 | -$11.54 | -$34.76 |
| Net income | ||||
| Net income | -$266.58 | -$819.38 | -$618.7 | -$789.61 |
| Income (for common shares) | -$266.58 | -$819.38 | -$618.7 | -$789.61 |
| (in millions $) | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 | 31 Dec 2022 |
|---|---|---|---|---|
| Net income | -$71.73 | -$72.91 | $21.24 | $32.23 |
| Operating activities | ||||
| Depreciation | $1.07 | $0.97 | $1.08 | $1.26 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $4.87 | $5.75 | $5.39 | $4.68 |
| Total cash flows from operations | -$61.85 | -$72.72 | -$86.64 | -$56.27 |
| Investing activities | ||||
| Capital expenditures | -$2.04 | -$0.75 | $92.74 | $101.89 |
| Investments | $64.12 | $7.69 | -$9.74 | $6.35 |
| Total cash flows from investing | $62.08 | $6.95 | $82.14 | $103.24 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$0.04 | -$0.45 | $130.46 | -$0.12 |
| Net borrowings | ||||
| Total cash flows from financing | -$0.04 | -$0.45 | $130.46 | -$0.12 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $0.2 | -$66.22 | $125.95 | $46.85 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Net income | -$266.58 | -$819.38 | -$618.7 | -$789.61 |
| Operating activities | ||||
| Depreciation | $5 | $19.65 | $19.36 | $17.43 |
| Business acquisitions & disposals | $110.3 | |||
| Stock-based compensation | $35.19 | $127.92 | $156.63 | $160.63 |
| Total cash flows from operations | -$352.95 | -$635.64 | -$470.35 | -$564.38 |
| Investing activities | ||||
| Capital expenditures | $93.79 | -$14.5 | -$28.99 | -$71.03 |
| Investments | $161.66 | $475.26 | -$55.36 | $584.06 |
| Total cash flows from investing | $250.45 | $562.56 | -$84.34 | $507.81 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $54.25 | $80.33 | $546.72 | $21.19 |
| Net borrowings | ||||
| Total cash flows from financing | $54.25 | -$93.95 | $546.72 | $21.19 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$48.25 | -$167.04 | -$7.98 | -$35.39 |
News
Fundamentals
| Market cap | $98.44M |
|---|---|
| Enterprise value | $236.80M |
| Shares outstanding | 107.00M |
| Revenue | $21.73M |
|---|---|
| EBITDA | -$95.08M |
| EBIT | -$99.46M |
| Net Income | -$91.17M |
| Revenue Q/Q | 17.35K% |
| Revenue Y/Y | -160.78% |
| P/E ratio | -1.08 |
|---|---|
| EV/Sales | 10.90 |
| EV/EBITDA | -2.49 |
| EV/EBIT | -2.38 |
| P/S ratio | 4.53 |
| P/B ratio | 0.44 |
| Book/Share | 2.10 |
| Cash/Share | 1.55 |
| EPS | -$0.85 |
|---|---|
| ROA | -14.44% |
| ROE | -34.32% |
| Debt/Equity | 1.83 |
|---|---|
| Net debt/EBITDA | -2.37 |
| Current ratio | 1.55 |
| Quick ratio | 1.42 |